FDA Enforcement
Class II
Terminated
FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740
Recall: Z-2540-2020
·
Reported July 15, 2020
Enforcement
- Recall Number
- Z-2540-2020
- Event ID
- 85897
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- FHC, Inc.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- July 15, 2020
- Initiation Date
- June 17, 2020
- Classification Date
- July 8, 2020
- Termination Date
- November 2, 2020
- Address
- 1201 Main St, Bowdoin, ME, 04287-7302, United States
Description
FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740
Reason
An electrical sub-circuit was not properly connected. Its purpose is to eliminate the possibility of interference with proper performance of the Guideline 5 Main Processing Unit, if an ESD event (greater than 6kV) were to occur.
Code Info
Serial Numbers: 45695, 48871, 48873, 48874, 46195, 46198
Distribution
US Nationwide distribution including in the states of CA, NC, TN, TX, WA.
Quantity
6 units